Pharmagreen Biotech Inc.
PHBI · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $3 | $0 | $0 |
| % Growth | 13.7% | – | – | – |
| Cost of Goods Sold | $2 | $9 | $0 | $0 |
| Gross Profit | $2 | -$6 | $0 | -$435 |
| % Margin | 50.9% | -215% | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $241 | $424 | $1,053 | $733 |
| SG&A Expenses | $250 | $468 | $1,070 | $753 |
| Sales & Mktg Exp. | $8 | $44 | $16 | $19 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $250 | $468 | $1,070 | $753 |
| Operating Income | -$248 | -$474 | -$1,070 | -$753 |
| % Margin | -7,272.7% | -15,810.5% | – | – |
| Other Income/Exp. Net | -$756 | -$95 | $194 | -$3,779 |
| Pre-Tax Income | -$1,004 | -$569 | -$876 | -$4,532 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,004 | -$569 | -$875 | -$4,532 |
| % Margin | -29,442.8% | -18,979.3% | – | – |
| EPS | -0.002 | -0.001 | -0.002 | -0.015 |
| % Growth | -25% | 45.5% | 85.7% | – |
| EPS Diluted | -0.002 | -0.001 | -0.002 | -0.015 |
| Weighted Avg Shares Out | 659,487 | 466,591 | 403,733 | 293,707 |
| Weighted Avg Shares Out Dil | 659,369 | 466,532 | 403,733 | 293,707 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $33 | $121 | $47 | $769 |
| Depreciation & Amortization | $248 | $474 | $1,070 | $0 |
| EBITDA | -$971 | $26 | $194 | -$3,763 |
| % Margin | -28,480.5% | 879.4% | – | – |